Skye Bioscience, Correlations

SKYE Stock  USD 2.86  0.15  4.98%   
The current 90-days correlation between Skye Bioscience, Common and Protagonist Therapeutics is 0.03 (i.e., Significant diversification). The correlation of Skye Bioscience, is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Skye Bioscience, Correlation With Market

Significant diversification

The correlation between Skye Bioscience, Common and DJI is 0.09 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Skye Bioscience, Common and DJI in the same portfolio, assuming nothing else is changed.
  
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Skye Bioscience, Common. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing.

Moving together with Skye Stock

  0.73PTN Palatin TechnologiesPairCorr
  0.72MBIO Mustang BioPairCorr
  0.61RANI Rani TherapeuticsPairCorr
  0.82ABOS Acumen PharmaceuticalsPairCorr
  0.68AQST Aquestive Therapeutics Buyout TrendPairCorr
  0.64AVDL Avadel PharmaceuticalsPairCorr

Moving against Skye Stock

  0.45DYAI Dyadic InternationalPairCorr
  0.49TELO Telomir Pharmaceuticals,PairCorr
  0.45BNTX BioNTech SEPairCorr

Related Correlations Analysis

Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.
High positive correlations   
CRMT
JPMCRM
JPMT
MSFTMETA
MRKA
XOMUBER
  
High negative correlations   
MRKJPM
MRKCRM
XOMMSFT
TUBER
CRMUBER
MRKT

Risk-Adjusted Indicators

There is a big difference between Skye Stock performing well and Skye Bioscience, Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Skye Bioscience,'s multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
META  1.20  0.14  0.09  0.25  1.39 
 3.22 
 8.02 
MSFT  0.89  0.01  0.00  0.03  1.62 
 1.83 
 8.14 
UBER  1.73 (0.30) 0.00 (0.30) 0.00 
 2.67 
 20.41 
F  1.43 (0.15) 0.00 (0.82) 0.00 
 2.53 
 11.21 
T  0.97  0.06  0.04  0.29  1.16 
 1.93 
 7.95 
A  1.25 (0.07) 0.00 (0.12) 0.00 
 2.71 
 9.02 
CRM  1.54  0.42  0.25  0.31  1.29 
 3.59 
 14.80 
JPM  1.03  0.15  0.13  0.11  1.09 
 1.65 
 15.87 
MRK  0.95 (0.26) 0.00 (1.06) 0.00 
 1.72 
 5.17 
XOM  0.91 (0.12) 0.00 (0.35) 0.00 
 1.83 
 6.06 

Skye Bioscience, Corporate Management

BA BAPresident, ChairmanProfile
Kaitlyn CPAChief OfficerProfile
FACE MDChief OfficerProfile
Tu MScChief OfficerProfile
Christopher TwittyChief OfficerProfile